<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>64</Volume>
      <Issue>02</Issue>
      <PubDate PubStatus="epublish">
        <Year>2026</Year>
        <Month>04</Month>
        <Day>03</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Moderate-Dose Prednisolone as an Effective Substitute for High-Dose Prednisolone in the Treatment of Idiopathic Granulomatous Mastitis: A Retrospective Study</title>
    <FirstPage>10986</FirstPage>
    <LastPage>10986</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Ramesh</FirstName>
        <LastName>Omranipour</LastName>
        <affiliation locale="en_US">1. Breast Disease Research Center, Cancer Institute, Tehran university of Medical Sciences, Tehran, Iran. 2. Department of Surgical Oncology, Cancer Institute, Imam Khomeini hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Negar</FirstName>
        <LastName>Mashoori</LastName>
        <affiliation locale="en_US">Department of Surgery, Imam Khomeini hospital, Tehran university of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sadaf</FirstName>
        <LastName>Alipour</LastName>
        <affiliation locale="en_US">Tehran University of Medical Sciences</affiliation>
      </Author>
      <Author>
        <FirstName>Azin</FirstName>
        <LastName>Saberi</LastName>
        <affiliation locale="en_US">Department of Surgery, Arash Women's Hospital, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>03</Month>
        <Day>08</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>02</Month>
        <Day>10</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Corticosteroids, generally prescribed at high doses, have been used with good results in the treatment of idiopathic granulomatous mastitis (IGM). However, side effects of steroids are a serious concern, and prescribing lower doses sound safer if they provide similar efficacy. Thus, this study was performed to investigate the effect of moderate-dose versus high-dose prednisolone on IGM. Medical records of IGM patients were evaluated retrospectively. Patients who received prednisolone were classified as the moderate-dose group (MDG, &lt;25 mg/day) and the high-dose group (HDG, &#x2265;25 mg/day); their response and recurrence rates were compared. Among 108 patients, 82.5% in HDG and 85.3% in MDG responded to treatment (P=0.7). Total recurrence was 21.7% and 22% in HDG and MDG, respectively (P=0.984). Moderate doses of corticosteroids may be used to treat IGM patients without decreasing the treatment efficacy. Prospective randomized trials are necessary to further clarify this issue.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/10986</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/10986/6018</pdf_url>
  </Article>
</Articles>
